# Clinical Study to Investigate the Safety and Efficacy of MLC601 in 150 Iranian Patients After Stroke

> **NCT01336153** · PHASE4 · COMPLETED · sponsor: **Shahid Beheshti University** · enrollment: 150 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** MLC601
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01336153
- **Lead sponsor:** Shahid Beheshti University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-01
- **Final completion:** 2010-12
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2011-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01336153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01336153, "Clinical Study to Investigate the Safety and Efficacy of MLC601 in 150 Iranian Patients After Stroke". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01336153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*